<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02955875</url>
  </required_header>
  <id_info>
    <org_study_id>PNU-2014-001</org_study_id>
    <nct_id>NCT02955875</nct_id>
  </id_info>
  <brief_title>Pharmaceutical Care Service in Diabetes</brief_title>
  <acronym>IMPACT4-DM</acronym>
  <official_title>Impact of Pharmaceutical Care Service for Type 2 Diabetes Mellitus Patients in Korea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pusan National University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pusan National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pusan National University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effectiveness of pharmaceutical care service in
      the management of poorly controlled type 2 diabetes mellitus.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Medications knowledge at 9 months</measure>
    <time_frame>9 months</time_frame>
    <description>Patients' knowledge about diabetes medications was measured by an instrument. The instrument includes items such as the name of medication, mechanism of action, dosage, and side effects.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c level at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Random blood glucose level at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol level at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of participants taking statins 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of participants managing diabetes complications at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morisky Medication Adherence Scale at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5-level version of the EQ-5D at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ Visual Analogue Scale at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Problem Areas In Diabetes-Korean questionnaire at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire-Korean at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness of pharmaceutical care at 9 months</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">257</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Pharmaceutical care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received systematically organized pharmaceutical care services, which were provided by pharmacists, in addition to the usual care. The usual care includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants received the usual care, which includes traditional consultation with pharmacists as well as traditional medical services provided by physicians, nurses, and dietitian.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pharmaceutical care</intervention_name>
    <description>Outpatient drug history management, drug regimen review, patient counseling and education before and/or after physician evaluation on the day of facility visit</description>
    <arm_group_label>Pharmaceutical care</arm_group_label>
    <other_name>Pharmaceutical service</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients who visit Endocrinology and Metabolism department of Pusan
        National University Hospital, are with type 2 diabetes mellitus, and meet one of the
        following criteria

          -  Who are diagnosed with type 2 diabetes mellitus for the first time

          -  Who need the education for medication or disease

          -  Who are with poorly controlled blood glucose

          -  Who have poor medication adherence

          -  Who have been hospitalized with diabetes complication or poorly controlled blood
             glucose

          -  Whose physician recommend the pharmaceutical care to them

        Exclusion Criteria: Patients who meet one of the following criteria

          -  Who are with gestational diabetes

          -  Who are not able to respond to questionnaires

          -  Who are with severe condition such as cerebrovascular disease, mental disorder, and
             acquired immune deficiency syndrome

          -  Who are not able to be followed-up during 9 months in Pusan National University
             Hospital
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2016</study_first_submitted>
  <study_first_submitted_qc>November 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2016</study_first_posted>
  <last_update_submitted>November 2, 2016</last_update_submitted>
  <last_update_submitted_qc>November 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pusan National University</investigator_affiliation>
    <investigator_full_name>Jeong-Hyun Yoon</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Diabetes Mellitus, Type 2</keyword>
  <keyword>Pharmaceutical Services</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

